ACSL4

There are 63 papers on ACSL4 in aging research: 4 observational studies in people, 46 in animals, 6 in cells, 7 reviews. The newest story, Oct 31, 2026: “Esketamine tied to less decline after surgery at 60–80 with sleep loss”.

Gene

63 papers study it14 findings

HGNCNCBI GeneTaxon

9 new papers in 30 daysSee all 63 papers on ACSL4

At a glance

The findings reach people, from one lab or study. 6 independent labs in 3 countries.

“abnormally high expression of the ferroptosis key marker ACSL4 was verified in the renal tubules of CKD patients (IgAN, MN, FSGS, LN, and DN)”
Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosisActa pharmacologica Sinica2023doi:10.1038/s41401-023-01156-w

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 6 independent labs in 3 countries
  • Funders: FWF Austrian Science Fund and 4 more
  • 2 of 9 findings with company ties
  • Humans4
  • Animals46
  • Cells6

Interventions

2

Vitamin C

downin cells1downin non-human primates1downin reviews1

3 studies
  1. Vitamin C inhibits ACSL4.

    “Vitamin C extends beyond its antioxidant activity by directly inhibiting ACSL4”

    Review

    Ferro-aging: iron-lipid axis in systemic decline

    Trends in endocrinology and metabolism: TEM

  2. Vitamin C inhibits ACSL4 in cells (functional screening and target engagement studies).

    “we identify vitamin C (VC) as a direct inhibitor of ACSL4”

    Cellsfunctional screening and target engagement studies

    Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates

    Cell metabolism

  3. Vitamin C inhibits ACSL4 in non-human primates (supraphysiological concentrations).

    “vitamin C (VC), traditionally viewed as a broad-spectrum antioxidant, has been proposed to interact with and inhibit ACSL4 activity at supraphysiological concentrations”

    Reviewsupraphysiological concentrations

    Vitamin C, ACSL4, and Ferro-Aging: Mechanistic Insights and Translational Perspectives from Primate Studies

    Aging and disease

More on Vitamin C

Abemaciclib

downin human cells1

1 study
  1. Abemaciclib inhibits ACSL4 in human cells (off-target).

    “the CDK4/6 inhibitor abemaciclib repolarized TAM-like macrophages toward a more inflammatory phenotype through off-target inhibition of ACSL4”

    Cellsoff-target

    Blocking a signal gives human immune cells tumor-linked traits

    Molecular biomedicine

More on Abemaciclib

Effects

7

Cellular senescence

upin animals1upin human cells1

2 studies
  1. ACSL4 increases cellular senescence (chronic lipid peroxidation).

    “this ACSL4-mediated process promotes cellular senescence”

    Animalschronic lipid peroxidation

    Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates

    Cell metabolism

  2. ACSL4 induces cellular senescence in human cells.

    “HCC-derived lEV ACSL4 increased the intracellular abundance of polyunsaturated fatty acid-containing lipids and remodeled the lipid profile to potentiate lipid peroxidation in peritumoral hepatocytes, resulting in hepatocyte senescence”

    Cellsliver

    Extracellular Vesicle-Packaged ACSL4 Induces Hepatocyte Senescence to Promote Hepatocellular Carcinoma Progression

    Cancer research

More on Cellular senescence

Lipid peroxidation

upin cells1

1 study
  1. ACSL4 increases lipid peroxidation in cells (AFB1 exposure; shown by Acsl4 silencing).

    “Acsl4 silencing or Fer-1 treatment attenuated ACSL4 induction, GPX4 loss, lipid peroxidation and inflammatory injury.”

    CellsAFB1 exposure; shown by Acsl4 silencing

    Aflatoxin B1-induced metabolic remodeling promotes liver injury through an H3K18la–ACSL4–ferroptosis axis attenuated by Urolithin A

    Metabolism: clinical and experimental

chronic lipid peroxidation

upin reviews1

1 study
  1. ACSL4 increases chronic lipid peroxidation.

    “the central role of ACSL4 in promoting membrane lipid remodeling and sustaining chronic lipid peroxidation”

    Review

    Ferro-aging: a potential driver of degenerative bone and joint diseases

    Cell communication and signaling : CCS

IL-1β release

downin human cells1

1 study
  1. ACSL4 decreases IL-1β release in human cells (despite elevated IL1B expression).

    “which promoted cell survival and restrained IL-1β release despite elevated IL1B expression”

    Cellsdespite elevated IL1B expression

    Blocking a signal gives human immune cells tumor-linked traits

    Molecular biomedicine

More on IL-1β release

Macrophage death

downin human cells1

1 study
  1. ACSL4 decreases macrophage death in human cells (shown by loss of ACSL4).

    “Loss of ACSL4 resulted in extensive macrophage death”

    Cellsshown by loss of ACSL4

    Blocking a signal gives human immune cells tumor-linked traits

    Molecular biomedicine

lipid peroxidation

upin primates1

1 study
  1. ACSL4 increases lipid peroxidation in primates (mediated by ACSL4).

    “conserved, iron-driven lipid peroxidation of primate aging mediated by ACSL4”

    Reviewmediated by ACSL4

    Vitamin C slows primate aging by targeting iron-driven lipid peroxidation

    Cell metabolism

Lipid-induced senolysis

is required forin silico1

1 study
  1. ACSL4 is required for lipid-induced senolysis in silico (lipid-induced senolysis).

    “ACSL4, LPCAT3, and ALOX15, important for lipid-induced senolysis”

    In silicolipid-induced senolysis

    Identification of lipid senolytics targeting senescent cells through ferroptosis induction

    bioRxiv : the preprint server for biologyPreprint

Upstream

1

YAP1

upin human cells1

1 study
  1. YAP1 activates ACSL4 in human cells (via YAP1 activity).

    “elevated levels of polyunsaturated fatty acids containing phospholipids, driven by the up-regulation of acyl-coenzyme A synthetase long-chain family member 4 through Yes1-associated protein 1 activity”

    Cellsvia YAP1 activity

    Selective Elimination of Genetic Variants of Human Embryonic Stem Cells from High Vulnerability to Ferroptosis

    Biomaterials research

More on YAP1

Associations

1

Chronic kidney disease

upin humans1

1 study
  1. ACSL4 is associated with chronic kidney disease in humans (renal tubules of patients with IgAN, MN, FSGS, LN or DN).

    “abnormally high expression of the ferroptosis key marker ACSL4 was verified in the renal tubules of CKD patients (IgAN, MN, FSGS, LN, and DN)”

    Humansrenal tubules of patients with IgAN, MN, FSGS, LN or DNrenal tubule

    Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis

    Acta pharmacologica Sinica

More on Chronic kidney disease

Latest

Dec 2025: 3Jan 2026: 4Feb 2026: 0Mar 2026: 3Apr 2026: 2May 2026: 4Jun 2026: 0Jul 2026: 1Aug 2026: 6Sep 2026: 5Oct 2026: 6Nov 2026: 539 papers in 12 months
Frontiers in Cell and Developmental Biology

Esketamine tied to less decline after surgery at 60–80 with sleep loss

Among sleep-deprived patients, cognitive decline seven days after surgery occurred in 32.5% without esketamine and 17.7% with it.Among sleep-deprived patients, cognitive decline seven days after surgery occurred in 32.5% without esketamine and 17.7% with it.

Cohort · 398 peopleInterventions
Ecotoxicology and Environmental Safety

Bisphenol A caused aging-like injury in lab-grown human bladder cells

Experiments in primary human bladder-lining cells found that silencing the gene for ACSL4, a protein, or adding vitamin C lessened the chemical’s effects.Experiments in primary human bladder-lining cells found that silencing the gene for ACSL4, a protein, or adding vitamin C lessened the chemical’s effects.

Human cell studyMechanisms
Communications Biology

Diabetes drug reduced kidney injury in diabetic rats

An experiment in diabetic rats found that dapagliflozin reduced kidney dysfunction and scarring alongside less iron-dependent cell death.An experiment in diabetic rats found that dapagliflozin reduced kidney dysfunction and scarring alongside less iron-dependent cell death.

Rat studyKidney
Life Sciences

Protein promoted iron-linked aging in spinal disc cells

Experiments in cells from the soft center of spinal discs identified a protein that promoted iron build-up, damage to fats and cell aging.Experiments in cells from the soft center of spinal discs identified a protein that promoted iron build-up, damage to fats and cell aging.

Cell studyMechanisms

See all 63 papers on ACSL4